BioXcel Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 1.94 M | $2.60 M | 5.53% | 15.86% |
| ARMISTICE CAPITAL, LLC | 05/15/2026 | 1.91 M | $2.56 M | 100.00% | 15.65% |
| OAKTREE CAPITAL MANAGEMENT LP | 05/20/2026 | 241.19 K | $323.19 K | 0.00% | 1.98% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 230.17 K | $308.73 K | 11.64% | 1.89% |
| 05/15/2026 | 207.34 K | $277.83 K | 100.00% | 1.70% | |
| JONES FINANCIAL COMPANIES LLLP | 05/15/2026 | 131.79 K | $166.05 K | -4.29% | 1.08% |
| MAN GROUP PLC | 05/15/2026 | 96.47 K | $129.27 K | 69.77% | 0.79% |
| STATE STREET CORP | 05/15/2026 | 92.12 K | $123.44 K | 45.71% | 0.75% |
| FMR LLC | 05/15/2026 | 90.30 K | $121.00 K | 0.00% | 0.74% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 84.92 K | $113.79 K | 100.00% | 0.70% |
| BLACKROCK, INC. | 05/13/2026 | 84.28 K | $112.94 K | -0.14% | 0.69% |
| WILEY BROS.-AINTREE CAPITAL, LLC | 05/15/2026 | 80.86 K | $108.36 K | 100.00% | 0.66% |
| UBS GROUP AG | 05/05/2026 | 52.79 K | $70.74 K | 37.68% | 0.43% |
| OAKTREE FUND ADVISORS, LLC | 05/20/2026 | 42.91 K | $57.50 K | 0.00% | 0.35% |
| HIGHTOWER ADVISORS, LLC | 05/05/2026 | 41.00 K | $54.94 K | 0.00% | 0.34% |
| NORTHERN TRUST CORP | 05/14/2026 | 36.31 K | $48.66 K | -5.36% | 0.30% |
| BEACON POINTE ADVISORS, LLC | 05/15/2026 | 18.88 K | $25.30 K | 100.00% | 0.15% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 16.21 K | $21.73 K | 2.95% | 0.13% |
| DIVERSIFY WEALTH MANAGEMENT, LLC | 05/01/2026 | 15.00 K | $15.60 K | 0.00% | 0.12% |
| PORTFOLIO STRATEGIES, INC. | 05/05/2026 | 12.18 K | $16.32 K | 0.00% | 0.10% |
| MORGAN STANLEY | 05/15/2026 | 10.59 K | $14.19 K | 623.22% | 0.09% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 4.32 K | $5.79 K | -0.14% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 1.72 K | $2.30 K | 100.00% | 0.01% |
| NEWEDGE ADVISORS, LLC | 06/03/2026 | 1.33 K | $1.78 K | 0.00% | 0.01% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 493 | $661 | 100.00% | 0.00% |
| 05/15/2026 | 334 | $447 | 100.00% | 0.00% | |
| WASHINGTON TRUST ADVISORS, INC. | 04/06/2026 | 160 | $214 | 0.00% | 0.00% |
| ANNIS GARDNER WHITING CAPITAL ADVISORS, LLC | 05/06/2026 | 156 | $210 | 39.29% | 0.00% |
| PARKSIDE FINANCIAL BANK & TRUST | 05/13/2026 | 112 | $151 | 0.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 05/18/2026 | 60 | $80 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 59 | $79 | 391.67% | 0.00% |
| JPMORGAN CHASE & CO | 05/13/2026 | 45 | $54 | 0.00% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 04/07/2026 | 25 | $31 | 0.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 05/07/2026 | 21 | $28 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 14 | $19 | -91.72% | 0.00% |
| IFP ADVISORS, INC | 04/13/2026 | 13 | $17 | -99.70% | 0.00% |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 05/15/2026 | 2 | $3 | 0.00% | 0.00% |
| US BANCORP \DE\ | 05/15/2026 | 1 | $1 | 0.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 05/13/2026 | 1 | $1 | -99.97% | 0.00% |
| TRIUMPH CAPITAL MANAGEMENT | 05/13/2026 | 1 | $1 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 05/11/2026 | 0 | $0 | -100.00% | 0.00% |
| GSA CAPITAL PARTNERS LLP | 05/08/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 05/12/2026 | 0 | $0 | -100.00% | 0.00% |
| ENGINEERS GATE MANAGER LP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 05/11/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BioXcel Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 57 institutional investors and hedge funds held shares of BioXcel Therapeutics Inc. The most heavily invested institutionals were:
MILLENNIUM MANAGEMENT LLC: 1.94 M
ARMISTICE CAPITAL, LLC: 1.91 M
OAKTREE CAPITAL MANAGEMENT LP: 241,188
GEODE CAPITAL MANAGEMENT, LLC: 230,168
JONES FINANCIAL COMPANIES LLLP: 131,789
Man Group plc: 96,473
44.57% of BioXcel Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 5.97 M shares in the last 24 months. This purchase volume represents approximately $10.33 M in transactions.